text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 86639-52-3 | Product Number: E0748

7-Ethyl-10-hydroxycamptothecin


Purity: >98.0%(HPLC)
Synonyms:
  • SN-38
Product Documents:
100MG
87,00 €
5   10  
1G
608,00 €
Contact Us 15  

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Product Number E0748
Purity / Analysis Method >98.0%(HPLC)
Molecular Formula / Molecular Weight C__2__2H__2__0N__2O__5 = 392.41 
Physical State (20 deg.C) Solid
Storage Temperature Frozen (<0°C)
Condition to Avoid Heat Sensitive
CAS RN 86639-52-3
Reaxys Registry Number 4829984
PubChem Substance ID 87559919
MDL Number

MFCD06762720

Specifications
Appearance White to Yellow to Green powder to crystal
Purity(HPLC) min. 98.0 area%
Purity(Nonaqueous Titration) min. 94.0 %
Specific rotation [a]20/D +20.0 to +30.0 deg(C=0.2, THF)
Properties (reference)
Melting Point 217 °C
Specific Rotation 21.5° (C=0.2,THF)
GHS
Pictogram Pictogram
Signal Word Danger
Hazard Statements H301 + H311 + H331 : Toxic if swallowed, in contact with skin or if inhaled.
Precautionary Statements P261 : Avoid breathing dust.
P264 : Wash skin thoroughly after handling.
P280 : Wear protective gloves/ protective clothing.
P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth.
P302 + P352 + P312 : IF ON SKIN: Wash with plenty of water. Call a POISON CENTER/doctor if you feel unwell.
P403 + P233 : Store in a well-ventilated place. Keep container tightly closed.
Related Laws:
RTECS# UQ0491000
Transport Information:
UN Number UN1544
Class 6.1
Packing Group III
HS Number 2933998090
Application
7-Ethyl-10-hydroxy-camptothecin (SN-38): An Active Metabolite of Irinotecan Hydrochloride (CPT-11) with a Topoisomerase-I Inhibitory Activity

7-Ethyl-10-hydroxy-camptothecin (SN-38) is a water insoluble biologically active metabolite of water soluble irinotecan hydrochloride (CPT-11) [I0714]. SN-38 has a topoisomerase-I inhibitory activity and is approximately 100-1000-fold more cytotoxic in vitro than CPT-11. Camptotecin and its derivatives interfere with DNA synthesis by inhibiting the enzyme topoisomerase-I. In order to prevent and correct of topological problems caused by the DNA double helix, topoisomerase-I catalyzes the relaxation of negatively supercoiled DNA, the knotting and unknotting DNA and the linking complementary rings of single-stranded DNA into double-stranded rings. Then the inhibition action induces breaks in single strand DNA. Eventually, this leads to double-strand DNA breaks and apoptosis or cell death. Recently, the use of polyethyleneglycolylated nanographene oxide for drug delivery of SN-38 has received widespread attention. (The product is for research purpose only.)

References


PubMed Literature


TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.